Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy-Reference-Cited by-同舟云学术

Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy

Published:2014-06-18 Issue:2 Volume:60 Page:576-587
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Gao Wei¹,Kim Heungnam¹,Feng Mingqian¹,Phung Yen¹,Xavier Charles P.²,Rubin Jeffrey S.²,Ho Mitchell¹

Affiliation:

1. Laboratory of Molecular Biology; National Cancer Institute, National Institutes of Health; Bethesda MD

2. Laboratory of Cellular and Molecular Biology; National Cancer Institute, National Institutes of Health; Bethesda MD

Funder

National Cancer Institute

Publisher

Wiley

Subject

Hepatology

Reference44 articles.

1. Glypican-3: a new target for cancer immunotherapy;Ho;Eur J Cancer,2011

2. Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma;Bengochea;Br J Cancer,2008

3. Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells;Wei;Mol Cancer,2009

4. Expression of Wnt pathway components frizzled and disheveled in colon cancer arising in patients with inflammatory bowel disease;You;Oncol Rep,2007

5. Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors;Gurney;Proc Natl Acad Sci U S A,2012

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Glypican-3 as a Molecular Target in Hepatocellular Carcinoma: Perspectives on Diagnosis and Precision Immunotherapy Strategies;Frontiers in Bioscience-Landmark;2024-07-24

2. Early monitoring values of oncogenic signalling molecules for hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2024-06-15

3. Wnt/β-Catenin signaling pathway in hepatocellular carcinoma: pathogenic role and therapeutic target;Frontiers in Oncology;2024-04-02

4. Glypican-3 deficiency in liver cancer upregulates MAPK/ERK pathway but decreases cell proliferation;American Journal of Cancer Research;2024

5. VAR2HP recognizing heparin‐like epitopes in targeted therapy and diagnosis of tumors;Proteoglycan Research;2024-01